Results 31 to 40 of about 8,316 (301)

Pharmacokinetics and Pharmacodynamics during Treatment with the Omeprazole 20 mg Enteric-Coated Tablet and 20 mg Capsule in Asymptomatic Duodenal Ulcer Patients

open access: yesCanadian Journal of Gastroenterology, 1997
This study compared the 24 h intragastric pH profile and bioavailability at repeated dosing conditions of the omeprazole 20 mg enteric-coated tablet versus the 20
ABR Thomson   +5 more
doaj   +1 more source

Development of a multiparticulate system containing enteric-release mini-tablets of omeprazole

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2014
The main aim of this study was to develop a multiparticulate system containing mini-tablets of omeprazole formulated with an enteric polymer with pH-dependent solubility.
Volnei Jose Tondo Filho   +3 more
doaj   +1 more source

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. [PDF]

open access: yes, 2006
BACKGROUND AND PURPOSE: Aspirin resistance may be relatively common and associated with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the lowest effective dose; however, it is not known whether the recent increased use of ...
Byrne, Michael F   +5 more
core   +1 more source

Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets [PDF]

open access: yesRomanian Journal of Pharmaceutical Practice, 2020
Mesalamine, 5-aminosalicylic acid or mesalazine is the standard therapy of inflammatory bowel disease. A small number of pharmaceutical dosage forms with mesalazine are on the market.
Adriana Aurelia Chiş   +5 more
doaj   +1 more source

Going Natural: Using polymers from nature for gastroresistant applications [PDF]

open access: yes, 2017
Nutraceuticals provide an additional health or medicinal benefit besides their nutritional value and are therefore marketed for the prevention and treatment of certain conditions.
Barbara Conway   +3 more
core   +1 more source

Optimal protection of stabilised dry live bacteria from bile toxicity in oral dosage forms by bile acid adsorbent resins [PDF]

open access: yes, 2010
We previously found that dried live bacteria of a vaccine strain can be temporarily sensitive to bile acids and suggested that Bile Adsorbing Resins (BAR) can be used in oral vaccine tablets to protect dried bacteria from intestinal bile. Here, we report
Chatterjee, Pratichi   +4 more
core   +1 more source

Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches [PDF]

open access: yes, 2015
Colon-specific drug delivery systems (CDDS) are desirable for the treatment of a range of local diseases such as ulcerative colitis, Crohn’s disease, irritable bowel syndrome, chronic pancreatitis, and colonic cancer.
Amidon, Seth, Brown, Jack, Dave, Vivek S
core   +1 more source

Practices of tablet splitting and dose uniformity of fragments at public hospitals in Ethiopia: A cross-sectional study supported by experimental findings

open access: yesPLoS ONE, 2022
Objective To assess the practices and dose uniformity of tablet splitting at selected public hospitals in Northwest Ethiopia. Methods A hybrid study method was employed to see the overall practices of tablet splitting. A prospective cross-sectional study
Asmamaw Emagn Kasahun   +2 more
doaj  

Determination of Eudragit® L100 in an Enteric-Coated Tablet Formulation Using Size-Exclusion Chromatography with Charged-Aerosol Detection

open access: yesScientia Pharmaceutica, 2018
Eudragit® L100 is a commonly used polymer in a coating layer of modified-release drug formulation to prevent drug release in the stomach. The amount of Eudragit® L100 in the formula determines the dissolution profile of drug at its release medium.
Marsella Widjaja   +3 more
doaj   +1 more source

Pharmaceutical quality of seven brands of diclofenac tablet on the Saudi market

open access: yesBMC Research Notes, 2020
Objective We previously reported the pharmaceutical quality of eight brands of 50 mg enteric-coated diclofenac sodium tablet available on the Saudi market.
Muhammad M. Hammami   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy